CONDITION

Diabetes Mellitus in Dogs

A metabolic condition where the body cannot regulate blood sugar levels effectively, affecting energy, weight, and hydration.

Why this matters now

Diabetes mellitus in dogs is diagnosed most commonly between seven and twelve years of age, though cases can occur in younger dogs. Female dogs are affected approximately twice as often as males, a pattern that relates to the influence of progesterone (during dioestrus and pregnancy) on insulin resistance. Certain breeds show increased predisposition, including Samoyeds, Australian Terriers, Miniature Schnauzers, Miniature and Toy Poodles, Pugs, and Bichon Frises, while other breeds such as German Shepherd Dogs and Golden Retrievers appear to have lower risk. Unlike cats, where Type 2 diabetes predominates, canine diabetes mellitus is overwhelmingly Type 1 in nature — characterised by immune-mediated destruction of the pancreatic beta cells, resulting in absolute insulin deficiency. This fundamental difference means that virtually all diabetic dogs require lifelong exogenous insulin therapy, as the beta cell destruction is irreversible. Other contributing factors may include pancreatitis (which can damage the insulin-producing tissue), concurrent endocrine diseases (Cushing's disease, hypothyroidism), and the diabetogenic effects of medications such as corticosteroids.

The onset of clinical diabetes in dogs often appears relatively abrupt compared to the insidious progression in cats, though the underlying beta cell destruction may have been progressing subclinically for weeks to months before the remaining functional capacity is exceeded. Once clinical signs develop, they typically progress over days to weeks without treatment, as the absolute insulin deficiency prevents glucose utilisation and forces the body into a catabolic state of fat and protein breakdown. The classic signs of polyuria, polydipsia, polyphagia, and weight loss may initially be subtle but tend to intensify as the metabolic disruption worsens. If left unmanaged, the condition can progress to diabetic ketoacidosis (DKA) — a life-threatening metabolic crisis characterised by accumulation of ketone bodies, metabolic acidosis, dehydration, and electrolyte imbalances. Once insulin therapy is initiated, the management journey becomes one of finding the appropriate insulin type, dose, and timing to maintain blood glucose levels within an acceptable range while minimising the risk of hypoglycaemia — a process that may require weeks to months of adjustment and ongoing monitoring.

Signals & patterns

Early signals

Increased water intake

Polydipsia is typically one of the first signs owners notice, as the dog begins drinking noticeably more water than usual. The water bowl may empty more quickly, the dog may seek water from unusual sources, or may drink for longer periods at a time. This increased thirst is the body's compensatory response to the excessive water lost through the kidneys as glucose spills into the urine and draws water with it by osmosis. The degree of polydipsia generally correlates with the severity of the hyperglycaemia and glucosuria.

Increased urination

Polyuria — producing larger volumes of urine more frequently — accompanies the polydipsia and is a direct consequence of the osmotic diuretic effect of glucose in the urine. Dogs may need to go outside more frequently, may have urinary accidents inside the house (particularly overnight), or may produce noticeably larger volumes at each urination. The urine is typically pale and dilute due to the high water content, and the increased frequency can be mistaken for a urinary tract problem rather than a metabolic condition.

Increased appetite

Polyphagia — increased hunger and food-seeking behaviour — develops because the cells cannot access the glucose circulating in the blood without adequate insulin, creating a paradoxical state of cellular starvation amidst abundance. Dogs may eat their meals more rapidly, beg for food more persistently, attempt to access food sources they previously ignored, or become competitive around food in multi-dog households. This increased appetite can initially be perceived positively by owners, who may interpret the enthusiasm as a sign of good health.

Weight loss despite eating

Progressive weight loss occurring despite maintained or increased food intake is a hallmark feature that often prompts veterinary attention. The weight loss reflects the body's inability to utilise glucose for energy, forcing reliance on fat and protein breakdown as alternative fuel sources. Muscle mass may decrease as protein is catabolised for gluconeogenesis, and fat stores diminish as lipolysis provides fatty acids for energy. The combination of increased appetite with obvious weight loss creates a paradox that is often the key observation that leads to investigation.

Reduced energy levels

Dogs may show a gradual decline in activity, seeming less interested in walks, play, or their usual activities, and spending more time resting or sleeping. This lethargy reflects the metabolic inefficiency of the diabetic state, where cells are deprived of their primary energy substrate despite its abundance in the blood. The change may be subtle initially and attributed to ageing or weather changes, but typically becomes more apparent as the disease progresses and the metabolic disruption intensifies.

Later signals

Diabetic cataracts

Cataract formation is one of the most common complications of canine diabetes mellitus, with studies suggesting that the majority of diabetic dogs will develop cataracts within approximately one to two years of diagnosis, regardless of the quality of glycaemic control. The cataracts develop due to accumulation of sorbitol within the lens — excess glucose enters the lens (which does not require insulin for glucose uptake) and is converted to sorbitol by the enzyme aldose reductase. Sorbitol, unable to cross the lens cell membranes, accumulates and draws water into the lens by osmosis, causing fibre swelling, disruption, and opacification. The progression can be rapid, with some dogs developing visually significant cataracts over the course of weeks, and the resulting vision impairment can substantially affect quality of life.

Recurrent infections

Hyperglycaemia impairs immune function through multiple mechanisms, including reduced neutrophil chemotaxis and phagocytosis, altered complement function, and the provision of a glucose-rich environment that favours microbial growth. This immunosuppression manifests as increased susceptibility to urinary tract infections, skin infections (pyoderma), ear infections, and respiratory infections that may respond to treatment but recur frequently. Urinary tract infections are particularly common due to the combination of glucosuria, dilute urine, and immunosuppression, and may be subclinical — detected only through urinalysis and culture rather than obvious signs.

Signs of diabetic ketoacidosis

If diabetes progresses to ketoacidosis, dogs may develop vomiting, loss of appetite, profound lethargy, weakness, dehydration (evidenced by dry gums, sunken eyes, and skin tenting), abdominal pain, and a distinctive sweet or fruity odour on the breath from acetone. Rapid or deep breathing (Kussmaul respiration) may develop as the body attempts to compensate for metabolic acidosis by expelling carbon dioxide. DKA represents a decompensation of the diabetic state, often triggered by concurrent illness, infection, or other physiological stressors, and represents a metabolic situation requiring intensive veterinary management.

Hepatomegaly

Liver enlargement develops in many diabetic dogs due to increased hepatic glucose uptake and glycogen storage (when insulin is provided) or fatty infiltration (hepatic lipidosis) during periods of uncontrolled lipolysis. The liver may become palpably enlarged on abdominal examination, and liver enzymes (ALT, ALP) are commonly elevated on blood work. While the hepatomegaly itself may not produce obvious clinical signs, it reflects the systemic metabolic impact of diabetes and may contribute to abdominal distension.

Click to read about the biological mechanisms

How this is usually investigated

Diagnosing diabetes mellitus in dogs is generally more straightforward than in cats, as dogs do not typically develop the degree of stress hyperglycaemia that complicates feline diagnosis. The investigation combines clinical assessment, blood glucose measurement, urinalysis, and evaluation for concurrent conditions or complications.

Blood glucose measurement

Purpose: A blood glucose measurement revealing persistent hyperglycaemia (typically above 11-14 mmol/L or 200-250 mg/dL) in conjunction with compatible clinical signs is the foundation of diabetes diagnosis in dogs. Unlike cats, dogs rarely develop clinically significant stress hyperglycaemia, making a single elevated blood glucose reading in a symptomatic dog highly suggestive of diabetes. Blood glucose can be measured rapidly using in-house portable glucometers or as part of a comprehensive biochemistry panel.
Considerations: While stress hyperglycaemia is less of a diagnostic confound in dogs than in cats, transient hyperglycaemia can occasionally occur with significant stress or concurrent illness. Blood glucose measurement provides a point-in-time value that does not indicate how long the hyperglycaemia has been present. In the context of ongoing management, individual blood glucose measurements provide limited information about overall glycaemic control compared to serial measurements (glucose curves) or longer-term indicators like fructosamine.

Urinalysis

Purpose: Urinalysis confirms glucosuria (glucose in the urine), demonstrating that blood glucose has exceeded the renal threshold — a finding that, combined with hyperglycaemia and clinical signs, confirms the diagnosis. Testing for ketonuria (ketones in the urine) identifies dogs that have progressed to a ketotic state, which influences the urgency and intensity of initial management. Urinalysis also assesses urine specific gravity (typically dilute in diabetic dogs due to osmotic diuresis) and screens for concurrent urinary tract infection through sediment examination and, ideally, urine culture.
Considerations: Urine culture is recommended at the time of diagnosis, as urinary tract infections are common in diabetic dogs and may be subclinical. A positive urine culture has important management implications, as untreated urinary infections can contribute to insulin resistance and hinder glycaemic control. The presence of ketonuria without clinical signs of ketoacidosis (subclinical ketonuria) may indicate early metabolic decompensation that warrants closer monitoring.

Comprehensive blood work

Purpose: A complete haematology and biochemistry panel at the time of diagnosis provides a comprehensive overview of the dog's metabolic status and screens for concurrent conditions that may complicate management. Characteristic findings may include elevated liver enzymes (ALT, ALP), hypercholesterolaemia, hypertriglyceridaemia, and sometimes mild to moderate azotaemia if dehydration is present. The blood work also helps identify concurrent endocrinopathies (Cushing's disease, hypothyroidism) that can cause insulin resistance and complicate glycaemic control.
Considerations: Elevated pancreatic lipase (fPLI or Spec cPL) may suggest concurrent pancreatitis, which is common in diabetic dogs and can both contribute to the development of diabetes and complicate its management. Thyroid hormone levels may be assessed, as hypothyroidism can coexist with diabetes and affect insulin sensitivity. The biochemistry panel provides a baseline against which future monitoring results can be compared to track the systemic effects of diabetes management over time.

Fructosamine measurement

Purpose: Fructosamine reflects the average blood glucose concentration over the preceding two to three weeks in dogs, providing a measure of overall glycaemic control that is unaffected by acute stress or single-point glucose fluctuations. At diagnosis, an elevated fructosamine confirms that the hyperglycaemia has been sustained. During ongoing management, serial fructosamine measurements help assess the effectiveness of the insulin regimen and guide dose adjustments, serving as a complement to blood glucose curves.
Considerations: Fructosamine can be falsely lowered by conditions that reduce serum protein levels (hypoproteinaemia, hyperlipidaemia) and falsely elevated by conditions that increase protein levels. It provides information about the average glucose level over weeks but cannot reveal the pattern of daily glucose fluctuations — a dog may have a normal fructosamine despite experiencing episodes of both hyperglycaemia and hypoglycaemia that average out. For this reason, fructosamine is most valuable when interpreted alongside glucose curves and clinical observations.

Blood glucose curves

Purpose: Serial blood glucose measurements taken every one to two hours over an eight to twelve-hour period create a glucose curve that reveals how blood glucose responds to insulin administration, feeding, and activity throughout the day. The curve identifies the glucose nadir (lowest point), the time at which it occurs, the duration of insulin action, and the degree of hyperglycaemia between insulin doses. This information is essential for optimising the insulin dose, determining whether the insulin type and frequency are appropriate, and identifying patterns such as the Somogyi effect (rebound hyperglycaemia following hypoglycaemia).
Considerations: In-clinic glucose curves may not accurately reflect the dog's typical glycaemic pattern at home due to differences in activity, stress, and feeding schedule. Home blood glucose monitoring, where owners learn to collect small blood samples from the ear margin or lip, can provide more representative data in some cases. The interpretation of glucose curves requires veterinary expertise, as multiple factors influence the pattern and simplistic dose adjustments based on single readings can be counterproductive. Continuous glucose monitoring systems are increasingly available for dogs and can provide detailed glycaemic profiles without repeated blood sampling.

Options & trade-offs

Management of canine diabetes mellitus centres on exogenous insulin therapy, as the immune-mediated destruction of beta cells makes endogenous insulin production insufficient. The management approach combines insulin therapy with dietary management, exercise regulation, and monitoring, with the goal of maintaining blood glucose levels within an acceptable range while preserving quality of life.

Insulin therapy

Twice-daily subcutaneous insulin injections form the cornerstone of canine diabetes management, as the immune-mediated beta cell destruction makes exogenous insulin essential for survival and metabolic control. Several insulin preparations are used in dogs, including intermediate-acting insulins (lente, NPH) and longer-acting formulations (protamine zinc insulin), with the choice influenced by the individual dog's pharmacokinetic response and glycaemic pattern. The insulin dose is started conservatively and titrated upward based on clinical response and glucose monitoring, with the aim of maintaining blood glucose within a range that controls clinical signs while minimising the risk of hypoglycaemia. Most dogs achieve reasonable glycaemic control with twice-daily insulin, though the optimal dose varies considerably between individuals.

Trade-offs: Insulin therapy requires commitment to twice-daily injections at approximately twelve-hour intervals, which restricts the owner's flexibility with schedules and travel. Learning to administer injections, handle and store insulin correctly, and recognise signs of both hyperglycaemia and hypoglycaemia requires an initial learning investment. The dose-finding period can be frustrating, as glycaemic control may take weeks to months to optimise, and dose requirements can change over time due to factors such as concurrent illness, changes in weight, or progression of concurrent conditions. The risk of insulin-induced hypoglycaemia — which can manifest as weakness, disorientation, trembling, seizures, or collapse — requires owner preparedness and a supply of glucose (honey or sugar syrup) for home treatment.

Dietary management

Dietary management complements insulin therapy by providing consistent, predictable nutritional input that facilitates glycaemic control. The recommended approach typically involves a high-fibre, complex-carbohydrate diet fed in consistent portions at consistent times, coordinated with insulin injections. Soluble and insoluble dietary fibre slow glucose absorption from the gastrointestinal tract, reducing post-meal glucose spikes and smoothing the glycaemic profile throughout the day. Consistency is particularly important in canine diabetes management — feeding the same food in the same amounts at the same times each day helps create a predictable glycaemic pattern against which insulin can be effectively dosed.

Trade-offs: The emphasis on dietary consistency limits the flexibility to vary food types, portion sizes, and feeding times, which some dogs and owners may find restrictive. Transitioning to a prescription diabetic diet may encounter resistance from dogs that are particular about their food, and the cost of prescription diets is typically higher than standard food. In overweight diabetic dogs, a concurrent weight loss programme is desirable (as weight loss can improve insulin sensitivity), but this must be carefully managed alongside insulin therapy to avoid hypoglycaemia as insulin requirements change with decreasing body weight. Treats and supplementary feeding need to be controlled and accounted for within the overall dietary plan.

Exercise regulation

Regular, consistent exercise forms an important component of diabetes management, as physical activity enhances insulin sensitivity and promotes glucose uptake by working muscles. The key principle is consistency — similar types, durations, and intensities of exercise at similar times each day help maintain a predictable pattern of glucose utilisation that complements the insulin and dietary regimen. Moderate daily walks at consistent times represent an ideal exercise pattern for most diabetic dogs, providing both physical and metabolic benefits while minimising the risk of exercise-induced hypoglycaemia.

Trade-offs: Vigorous or unpredictable exercise can cause significant drops in blood glucose that, combined with the effects of exogenous insulin, may precipitate hypoglycaemia. This means that spontaneous intense activity (such as extended off-lead running or vigorous play sessions) carries more risk in diabetic dogs than in non-diabetic individuals, particularly if it occurs during the period of peak insulin action. Owners need to understand the relationship between exercise, insulin, and blood glucose, and may need to provide additional food before unusually active periods. Weather conditions, the dog's physical capability, and owner schedule all influence the ability to maintain exercise consistency.

Monitoring and ongoing management

Successful long-term diabetes management relies on a programme of regular monitoring that includes periodic blood glucose curves (in clinic or at home), fructosamine measurements, urinalysis to check for glucosuria and urinary tract infections, and assessment of clinical signs and body condition. Home monitoring of clinical signs — water intake, urine output, appetite, weight, energy levels — provides valuable daily information about glycaemic control between veterinary assessments. Some owners learn to perform blood glucose measurements at home using portable glucometers, providing more representative data than in-clinic measurements and enabling earlier detection of glycaemic changes.

Trade-offs: The monitoring programme involves ongoing veterinary visits and associated costs, with more frequent visits needed during the initial stabilisation period and at times of dose adjustment. Home monitoring requires owner engagement and observation skills, and the interpretation of home observations in the context of the overall management plan requires ongoing communication with the veterinary team. Blood glucose curves, whether performed in clinic or at home, represent snapshots that may not capture day-to-day variation. The management plan may need periodic revision as the dog ages, develops concurrent conditions, or experiences changes in insulin requirements.

Common misconceptions

Misconception:

"Diabetes in dogs can be cured or managed with diet alone, similar to some human cases."

Reality:

Canine diabetes mellitus is fundamentally different from the dietary-responsive forms of diabetes that may be encountered in humans or cats. Because the predominant form in dogs involves immune-mediated destruction of the insulin-producing beta cells (analogous to Type 1 diabetes in humans), the resulting insulin deficiency is permanent and cannot be compensated for through dietary modification alone. While diet is an important component of diabetes management — providing consistent nutritional input that facilitates glycaemic control — it works in conjunction with insulin therapy rather than as a substitute for it. Dogs with established diabetes require exogenous insulin for survival, and attempting to manage the condition with diet alone would result in progressive metabolic deterioration.

Misconception:

"A well-managed diabetic dog should have normal blood glucose levels at all times."

Reality:

Achieving blood glucose levels that remain consistently within the normal non-diabetic range throughout the day is neither a realistic nor necessarily a desirable goal in canine diabetes management. Attempting to maintain blood glucose within the tight normal range significantly increases the risk of hypoglycaemia, which can be more acutely dangerous than moderate hyperglycaemia. The practical goal of management is to keep blood glucose levels within an acceptable range that controls clinical signs (resolving excessive thirst, urination, and weight loss) while avoiding dangerous lows. Blood glucose levels will naturally fluctuate throughout the day in response to meals, activity, and insulin action, and moderate fluctuations within an acceptable range represent good practical control rather than treatment failure.

Misconception:

"Diabetic dogs cannot live happy, active lives and have a poor quality of life."

Reality:

With appropriate management, many diabetic dogs maintain an excellent quality of life that is comparable to non-diabetic dogs of similar age and health status. Once the initial stabilisation period is navigated and a suitable insulin regimen is established, the daily routine of insulin injections and consistent feeding typically becomes integrated into normal life with minimal disruption. Diabetic dogs can enjoy walks, play, social interactions, and all the activities they enjoyed before diagnosis. The condition does require ongoing commitment from owners, but most find that the management becomes routine and that the investment in consistent care is rewarded with a comfortable, active companion. Survival times of several years following diagnosis are well documented in dogs with well-managed diabetes.

Canine diabetes mellitus is a condition that, once established, becomes a permanent aspect of the dog's health landscape requiring ongoing daily management. Understanding that the disease reflects an irreversible loss of insulin-producing capacity helps frame the expectation that insulin therapy will be lifelong rather than temporary. The management journey involves developing a rhythm of insulin administration, feeding, exercise, and monitoring that becomes integrated into the daily routine. While the initial adjustment period requires significant learning and adaptation, many dogs with well-managed diabetes maintain excellent quality of life for years, and the relationship between consistent management and stable glycaemic control tends to become more intuitive over time.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS